+1-617-394-8820 contact@baybiosciences.com
Bay Biosciences provides high quality, clinical grade bio-samples, sera (serum), plasma and peripheral blood mononuclear cells (PBMC) biofluid specimens from patients diagnosed with cystic fibrosis. The PBMCsera (serum) and plasma samples are processed from patient’s peripheral whole-blood using customized processing protocols. The sera (serum), plasma and PBMC biofluid specimens are processed from cystic fibrosis patient’s peripheral whole-blood using customized collection and processing protocols. The cystic fibrosis matched biofluid samples are collected from unique patients diagnosed with cystic fibrosis and are provided to a valued pharmaceutical customer for research, diagnostics, discovery and drug development. Detailed clinical data, cystic fibrosis patient’s history, symptoms, complete blood count (CBC), serology, MRI, histopathology information, elevated biomarker levels, genetic and metabolic information associated with cystic fibrosis specimens is provided to a valued customer for research, development and drug discovery. The cystic fibrosis sera (serum), plasma and peripheral blood mononuclear cells (PBMC) biofluids are processed from patients peripheral whole-blood using customized collection and processing. protocols.

Cystic Fibrosis (CF) Disease Overview

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs, digestive system and other organs in the body. Cystic fibrosis affects the cells that produce mucus, sweat and digestive juices. These secreted fluids are normally thin and slippery. But in patients with Cystic Fibrosis, a defective gene causes the secretions to become sticky and thick. Instead of acting as lubricants, the secretions plug up tubes, ducts and passage ways, especially in the lungs and pancreas. Although cystic fibrosis is progressive and requires daily care, patients with Cystic Fibrosis are usually able to attend school and work. They often have a better quality of life than patients with Cystic Fibrosis had in previous decades. Improvements in screening and treatments mean that patients with Cystic Fibrosis now may live into their mid- to late 30s or 40s, and some are living into their 50s.

Cystic Fibrosis Symptoms

In the United States because of newborn screening, cystic fibrosis can be diagnosed within the first month of life, before symptoms develop. But Cystic Fibrosis patients born before newborn screening became available may not be diagnosed until the signs and symptoms of Cystic Fibrosis disease show up. Cystic fibrosis signs and symptoms vary, depending on the severity of the disease. Even in the same person, symptoms may worsen or improve as time passes. Some patients may not experience symptoms until their teenage years or adulthood. Patients who are not diagnosed until adulthood usually have milder disease and are more likely to have atypical symptoms, such as recurring bouts of an inflamed pancreas (pancreatitis), infertility and recurring pneumonia. Patients with cystic fibrosis have a higher than normal level of salt in their sweat. Parents often can taste the salt when they kiss their children. Most of the other signs and symptoms of Cystic Fibrosis affect the respiratory system and digestive system.

Cystic Fibrosis Causes

In Cystic Fibrosis (CF) disease, a defect (mutations) in a gene, the cystic fibrosis transmembrane conductance regulator (CFTR) gene changes a protein that regulates the movement of salt in and out of cells. The result is thick, sticky mucus in the respiratory, digestive and reproductive systems, as well as increased salt in sweat. Many different defects can occur in the gene. The type of gene mutation is associated with the severity of the condition. Children need to inherit one copy of the gene from each parent in order to have the disease. If children inherit only one copy, they won’t develop cystic fibrosis. However, they will be carriers and could pass the gene to their own children.

Cystic Fibrosis Disease Risk Factors

Because cystic fibrosis disease is an inherited disorder, it runs in families, so family history is a risk factor. Although Cystic Fibrosis disease occurs in all races, it’s most common in white people of Northern European ancestry.

Cystic Fibrosis Diagnosis

Cystic fibrosis diagnosis requires clinical symptoms consistent with cystic fibrosis in at least one organ system and evidence of CFTR dysfunction usually based on an abnormal sweat chloride test or the presence of mutations in the CFTR gene

Following are some of the diagnostic tests that may be performed for the diagnosis of cystic fibrosis disease:

Immuno-reactive Trypsinogen (IRT) Test

The immuno-reactive trypsinogen (IRT) test is a standard newborn screening test that checks for abnormal levels of the protein called IRT in the blood. A high level of IRT may be a sign of cystic fibrosis. However, further testing is required to confirm the diagnosis.

Sweat Chloride Test

Sweat chloride test checks for increased levels of salt in the sweat, it is the most commonly used test for diagnosing cystic fibrosis. It The test is performed by using a chemical that makes the skin sweat when triggered by a weak electric current. Patients sweat is collected on a pad or paper and then analyzed in a lab. A diagnosis of cystic fibrosis is made if the sweat is saltier than normal.

Sputum Test

During a sputum test a sample of mucus is taken which can can confirm the presence of a lung infection. Sputum test can also show the types of germs that are present and determine which antibiotics work best to treat them.

Chest X-ray

A chest X-ray is useful in revealing swelling in the lungs due to blockages in the respiratory passageways.

CT Scan

CT scan creates detailed images of the body by using a combination of X-rays taken from many different directions. These images allows your doctor to view internal structures, such as the liver and pancreas, making it easier to assess the extent of organ damage caused by cystic fibrosis.

Pulmonary function tests (PFTs)

Pulmonary function tests (PFTs) determine whether the lungs are working properly. The tests can help measure how much air can be inhaled or exhaled and how well the lungs transport oxygen to the rest of the body. Any abnormalities in these functions may indicate cystic fibrosis.

This image has an empty alt attribute; its file name is Bay-Biosciences-blood-plasma-sample-02151913-300x200.jpg
Bay Biosciences is a global leader in providing researchers with high quality, clinical grade, fully characterized human tissue samples, bio-specimens and human bio-fluid collections from cancer (tumor) tissue, cancer sera (serum), cancer plasmacancer PBMC and human tissue samples from most other therapeutic areas and diseases. Bay Biosciences maintains and manages it’s own bio-repository, human tissue bank (biobank) consisting of thousands of diseased samples (specimens) and from normal healthy donors available in all formats and types. Our biobank procures and stores fully consented, deidentified and institutional review boards (IRB) approved human tissue samples and matched controls. All our human human tissue collections, human specimens and human bio-fluids are provided with detailed samples associated patient’s clinical data. This critical patient’s clinical data includes information relating to their past and current disease, treatment history, lifestyle choices, biomarkers and genetic information. Patient’s data is extremely valuable for researchers and is used to help identify new effective treatments (drug discovery & development) in oncology, other therapeutic areas and diseases. This clinical information is critical to demonstrate their impact, monitor the safety of medicines, testing & diagnostics, and generate new knowledge about the causes of disease and illness.  Bay Biosciences banks wide variety of human tissue samples and biological samples including cryogenically preserved -80°C, fresh, fresh frozen tissue samplestumor tissue samples, FFPE’s, tissue slides, with matching human bio-fluids, whole blood and blood derived products such as serumplasma and PBMC’s. Bay Biosciences is a global leader in collecting and providing human tissue samples according to the researchers specified requirements and customized, tailor made collection protocols. Please contact us anytime to discuss your special research projects and customized human tissue sample requirements. Bay Biosciences provides human tissue samples (human specimens) from diseased and normal healthy donors; including peripheral whole-blood, amniotic fluid, bronchoalveolar lavage fluid (BAL), sputum, pleural effusion, cerebrospinal fluid (CSF), serum (sera), plasma, peripheral blood mononuclear cells (PBMC’s), saliva, Buffy coat, urine, stool samples, aqueous humor, vitreous humor, kidney stones, renal calculi, nephrolithiasis, urolithiasis and other bodily fluids from most diseases including cancer. We can also procure most human bio-specimens and can do special collections and requests of human samples that are difficult to find. All our human tissue samples are procured through IRB approved clinical protocols and procedures.  In addition to the standard processing protocols Bay Biosciences can also provide human plasmaserum, PBMC bio-fluid samples using custom processing protocols, you can buy donor specific sample collections in higher volumes and specified sample aliquoting from us. Bay Biosciences also provides human samples from normal healthy donors, volunteers, for controls and clinical research, contact us Now. 日本のお客様は、ベイバイオサイエンスジャパンBay Biosciences Japanまたはhttp://baybiosciences-jp.com/contact/までご連絡ください。